Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers
Conclusion Febuxostat seemed efficient in gouty patients with stage 4/5 chronic kidney disease. However, safety data were not clear regarding renal function. Larger studies are needed to assess safety.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
More News: Academia | Allopurinol | Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Endocrinology | Gout | Heart | Hypertension | Kidney Transplant | Kidney Transplantation | Nutrition | Study | Transplants | Urology & Nephrology